ReviewCancers2023
CDK4/6 Inhibitors in Pancreatobiliary Cancers: Opportunities and Challenges.
Tatjana Arsenijevic et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it
ReviewCancers2023
Tatjana Arsenijevic et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.